NCT04427956View on ClinicalTrials.gov

Corneal Crosslinking Treatment Study

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

May 23, 2017

Primary Completion Date

November 19, 2024

Study Completion Date

November 19, 2024

Conditions
Progressive Keratoconus
Interventions
PROCEDURE

Corneal crosslinking: CXL (UVA 9mW/cm2)

CXL treatment with UVA-radiation (9mW/cm2) with a 10 minute irradiation protocol.

DRUG

Isotonic riboflavin

CXL protocol with isotonic riboflavin

DRUG

Hypotonic riboflavin

CXL protocol with hypotonic riboflavin

PROCEDURE

Iontophoresis

CXL protocol with iontophoresis and ricrolin

Trial Locations (1)

22242

Skåne University Hospital, Lund

All Listed Sponsors
lead

Region Skane

OTHER

NCT04427956 - Corneal Crosslinking Treatment Study | Biotech Hunter | Biotech Hunter